Levels of anticardiolipin and anti-β2-glycoprotein I antibodies in healthy newborn cord sera

Pascale Nicaise-Roland; Marie-Hélène Aurousseau; Anne Delaval; Sabine Grootenboer-Mignot; Margarita Hurtado; Lionel Carbillon; Olivier Fain; Michele Uzan; Eric Lachassine; Marie-Claire Boffa; Sylvie Chollet-Martin

doi:10.1160/TH08-02-0074

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2008; 99(06): 1124-1126
DOI: 10.1160/TH08-02-0074

Letters to the Editor

Schattauer GmbH

Levels of anticardiolipin and anti-β₂-glycoprotein I antibodies in healthy newborn cord sera

Autoren

Pascale Nicaise-Roland

¹AP-HP, Bichat-Claude Bernard Hospital, Haematology and Immunology Department, Paris, France
Marie-Hélène Aurousseau

²AP-HP, J Verdier Hospital, Haematology Department, Bondy, France
Anne Delaval

¹AP-HP, Bichat-Claude Bernard Hospital, Haematology and Immunology Department, Paris, France
Sabine Grootenboer-Mignot

¹AP-HP, Bichat-Claude Bernard Hospital, Haematology and Immunology Department, Paris, France
Margarita Hurtado

¹AP-HP, Bichat-Claude Bernard Hospital, Haematology and Immunology Department, Paris, France

³Paris-Sud 11 University , Inserm IFR 141, UMR 756,Chatenay-Malabry, France
Lionel Carbillon

⁴AP-HP, J Verdier Hospital, Gynaecology and Obstetrics, Bondy, France
Olivier Fain

⁵AP-HP, J Verdier Hospital, Internal Medicine Department, Bondy, France
Michele Uzan

⁴AP-HP, J Verdier Hospital, Gynaecology and Obstetrics, Bondy, France
Eric Lachassine

⁶AP-HP, J Verdier Hospital, Paediatric Department, Bondy, France
Marie-Claire Boffa

²AP-HP, J Verdier Hospital, Haematology Department, Bondy, France
Sylvie Chollet-Martin

¹AP-HP, Bichat-Claude Bernard Hospital, Haematology and Immunology Department, Paris, France

³Paris-Sud 11 University , Inserm IFR 141, UMR 756,Chatenay-Malabry, France

Abstract

Volltext

Referenzen

References
1 Myakis S, Lockhin MD, Atsumi T. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
2 Ruffati A, Tonello M, Del Ross T. et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost 2006; 96: 337-341.
3 Boffa MC, Lachassine E. Infant perinatal thrombosis and antiphospholipid antibodies. A review. Lupus 2007; 16: 634-641.
4 Motta M, Chirico G. Rebaioli et al. Anticardiolipin and anti-β2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study. Am J Pernatol 2006; 23: 247-251.
5 Cohen SB, Goldenberg M, Rabinovici J. et al. Anticardiolipin antibodies in fetal blood and amniotic fluid derived from patients with the antiphospholipid syndrome. Hum Reprod 2000; 15: 1170-1172.
6 Soares Rolim AM, Castro M, Santiago MB. Neonatal antiphospholipid syndrome. Lupus 2006; 15: 301-303.
7 Carbillon L, Letamendia-Richard E, Lachassine E. et al. Neonatal thrombosis associated with maternal antiphospholipid syndrome. J Pediat Hematol Oncol 2005; 27: 56.
8 Cabiedes J, Trjo-Hernadez J, Loredo-Abdala A. et al. Anticardiolipin, anticardiolipin plus bovine or human β2glycoprotein I and anti human β2glycoprotein I antibodies in a healthy infant population. Arch Med Res 2002; 33: 175-179.
9 Avcin T, Ambrozic A, Kuhar M. et al. Anticardiolipin and anti-β2 glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatology 2001; 40: 565-573.
10 Rapizzi E, Ruffati A, Tonello M. et al. Correction for age of anticardiolipin antibodies cut-off points. J Clin Lab Anal 2000; 14: 87-90.
11 Gattorno M, Buoncompagni A, Molinari AC. et al. Antiphosholipid antibodies in pediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high titer anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome. Br J Rheumatol 1995; 34: 873-881.
12 Siamopoulou-Mavridou A, Mavridis AK, Terzoglou C. et al. Autoantibodies in Greek juvenile chronic arthritis patients. Clin Exp Rheumatol 1991; 9: 647-652.
13 Serra CR, Rodrigues SH, Silva NP. et al. Clinical significance of anticardiolipin antibodies in juvenile idiopathic arthritis. Clin Exp Rheumatol 1999; 17: 375-380.
14 Tincani A, Allegri F, Ballestrieri G. et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 2004; 114: 553-558.
15 Jones JV, Eastwood BJ. Jones et al. Antiphospholipid antibodies in a healthy population: methods for estimating the distribution. J Rheumatol 1995; 22: 55-61.
16 Hayward AR. The human fetus and newborn: development of the immune response. Birth defects Orig Artic Sem 1983; 19: 289-294.
17 Angelini L, Ravelli A, Caporali R. et al. High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia. Pediatrics 1994; 94: 500-503.
18 Reber G, Shousboe I, Tincani A. et al. Inter-laboratory variability of antiβ2glycoprotein I measurements. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group. Thromb Haemost 2002; 88: 66-73.
19 Boffa MC, Aurousseau MH, Lachassine E. et al. European register of babies born to mothers with antiphospholipid syndrome. Lupus 2004; 13: 1-5.